ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      Subscribe Login/Register Profile Icon
      S&P 500
      5,222.68
      0.16%
      US Tech 100
      17,720.40
      0.21%
      Dow Jones
      39,512.84
      0.32%
      Brent Oil
      82.785
      0.49%
      Bitcoin
      63,038.63
      2.59%
      Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ
      6. TScan Therapeutics Inc (TCRX)

      7. TScan Therapeutics Inc (TCRX) News

      TCRX

      TScan Therapeutics (TCRX)

      TScan Therapeutics Inc
      		Date:
      Sort by:
       Showing the most relevant articles for your search:NASDAQ:TCRX
      DateTimeSourceHeadlineSymbolCompany
      05/09/20247:00AMGlobeNewswire Inc.TScan Therapeutics Announces First Patient Dosed in Phase 1 Clinical Trial Evaluating TCR-T Therapy for the Treatment of Solid TumorsNASDAQ:TCRXTScan Therapeutics Inc
      04/24/20244:05PMGlobeNewswire Inc.TScan Therapeutics Announces Upcoming Presentations at the 2024 American Society of Clinical Oncology Annual MeetingNASDAQ:TCRXTScan Therapeutics Inc
      04/24/202411:03AMGlobeNewswire Inc.TScan Therapeutics Announces Exercise of Underwriters' Option to Purchase Additional SharesNASDAQ:TCRXTScan Therapeutics Inc
      04/22/20245:01PMGlobeNewswire Inc.TScan Therapeutics Announces Upcoming Presentations at the American Society of Gene and Cell Therapy 27th Annual MeetingNASDAQ:TCRXTScan Therapeutics Inc
      04/19/202410:05AMGlobeNewswire Inc.TScan Therapeutics Announces Closing of Upsized Public OfferingNASDAQ:TCRXTScan Therapeutics Inc
      04/17/202412:30AMGlobeNewswire Inc.TScan Therapeutics Announces Pricing of Upsized $150 Million Public OfferingNASDAQ:TCRXTScan Therapeutics Inc
      04/16/20244:25PMGlobeNewswire Inc.TScan Therapeutics Announces Launch of $125 Million Proposed Public OfferingNASDAQ:TCRXTScan Therapeutics Inc
      04/16/20244:01PMGlobeNewswire Inc.TScan Therapeutics Provides Clinical Pipeline Update and Highlights Near-Term PrioritiesNASDAQ:TCRXTScan Therapeutics Inc
      04/08/20248:00AMGlobeNewswire Inc.TScan Therapeutics Appoints Seasoned Hematology and Oncology Expert Chrystal U. Louis, M.D., M.P.H., as Chief Medical OfficerNASDAQ:TCRXTScan Therapeutics Inc
      04/02/20247:00AMGlobeNewswire Inc.TScan Therapeutics Announces Upcoming Presentation at the 23rd Annual Needham Virtual Healthcare ConferenceNASDAQ:TCRXTScan Therapeutics Inc
      03/06/20244:11PMEdgar (US Regulatory)Form S-3 - Registration statement under Securities Act of 1933NASDAQ:TCRXTScan Therapeutics Inc
      03/06/20244:05PMEdgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:TCRXTScan Therapeutics Inc
      03/06/20247:30AMEdgar (US Regulatory)Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]NASDAQ:TCRXTScan Therapeutics Inc
      03/06/20247:15AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:TCRXTScan Therapeutics Inc
      02/14/20244:45PMEdgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:TCRXTScan Therapeutics Inc
      01/29/20247:15AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:TCRXTScan Therapeutics Inc
      12/11/20238:00AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:TCRXTScan Therapeutics Inc
      12/07/20237:15AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:TCRXTScan Therapeutics Inc
      11/09/20237:30AMEdgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:TCRXTScan Therapeutics Inc
      11/09/20237:15AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:TCRXTScan Therapeutics Inc
      08/29/20238:02AMDow Jones NewsTScan Gets FDA Clearance of Investigational New Drug Application for Cancer TreatmentNASDAQ:TCRXTScan Therapeutics Inc
      08/10/20237:30AMEdgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:TCRXTScan Therapeutics Inc
      08/10/20237:15AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:TCRXTScan Therapeutics Inc
      07/24/20237:39PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:TCRXTScan Therapeutics Inc
      07/24/20237:31PMEdgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:TCRXTScan Therapeutics Inc
      06/29/20238:31AMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:TCRXTScan Therapeutics Inc
      06/29/20238:30AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:TCRXTScan Therapeutics Inc
      06/16/20236:01AMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:TCRXTScan Therapeutics Inc
      06/15/20236:20PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:TCRXTScan Therapeutics Inc
      06/15/20236:17PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:TCRXTScan Therapeutics Inc
       Showing the most relevant articles for your search:NASDAQ:TCRX

      Your Recent History

      HUOB
      STEEMETH
      Steem
      Delayed Upgrade Clock